Found: 6
Select item for more details and to access through your institution.
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 2, p. 250, doi. 10.1016/j.molonc.2013.11.005
- By:
- Publication type:
- Article
Natural Killer T Cells in Advanced Melanoma Patients Treated with Tremelimumab.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0076829
- By:
- Publication type:
- Article
CRAF R391W is a melanoma driver oncogene.
- Published in:
- Scientific Reports, 2016, p. 27454, doi. 10.1038/srep27454
- By:
- Publication type:
- Article
Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma
- Published in:
- Molecular Cancer, 2015, v. 14, n. 1, p. 128, doi. 10.1186/s12943-015-0393-2
- By:
- Publication type:
- Article
Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma.
- Published in:
- Molecular Cancer, 2015, v. 14, n. 1, p. 1, doi. 10.1186/s12943-015-0293-5
- By:
- Publication type:
- Article
Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma.
- Published in:
- Molecular Cancer, 2014, v. 13, p. 1, doi. 10.1186/1476-4598-13-194
- By:
- Publication type:
- Article